CIK 0001870144 · <br>Emerging growth company
Cardio Diagnostics Holdings, Inc.
Sign in to watch- Ticker
- CDIO
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870925574
- Phone
- 855-226-9991
- Business address
- 311 W. SUPERIOR STREET, SUITE 444, CHICAGO, IL, 60645
- Former names
- Mana Capital Acquisition Corp.
Securities
- CDIO Common stock Nasdaq
- CDIOW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | Fung Peter K Director | Grant or award · Stock Options (Right to Buy) | +3,286 | $1.90 | $6K | 15,656 |
| 2026-09-30 | Betts Wendy J Director | Grant or award · Stock Options (Right to Buy) | +3,286 | $1.90 | $6K | 15,656 |
| 2026-09-30 | Burton Paul Frederick Director | Grant or award · Stock Options (Right to Buy) | +3,286 | $1.90 | $6K | 16,607 |
| 2026-09-30 | Intrater James Director | Grant or award · Stock Options (Right to Buy) | +3,286 | $1.90 | $6K | 16,607 |
| 2026-06-30 | Fung Peter K Director | Grant or award · Stock Options (Right to Buy) | +2,854 | $2.19 | $6K | 12,367 |
| 2026-06-30 | Betts Wendy J Director | Grant or award · Stock Options (Right to Buy) | +2,854 | $2.19 | $6K | 12,367 |
| 2026-06-30 | Burton Paul Frederick Director | Grant or award · Stock Options (Right to Buy) | +2,854 | $2.19 | $6K | 13,318 |
| 2026-06-30 | Intrater James Director | Grant or award · Stock Options (Right to Buy) | +2,854 | $2.19 | $6K | 13,318 |
| 2026-03-31 | Fung Peter K Director | Grant or award · Stock Options (Right to Buy) | +3,205 | $1.95 | $6K | 9,513 |
| 2026-03-31 | Betts Wendy J Director | Grant or award · Stock Options (Right to Buy) | +3,205 | $1.95 | $6K | 9,513 |
| 2026-03-31 | Burton Paul Frederick Director | Grant or award · Stock Options (Right to Buy) | +3,205 | $1.95 | $6K | 10,464 |
| 2026-03-31 | Intrater James Director | Grant or award · Stock Options (Right to Buy) | +3,205 | $1.95 | $6K | 10,464 |
| 2025-12-31 | Fung Peter K Director | Grant or award · Stock Options (Right to Buy) | +2,306 | $2.71 | $6K | 6,308 |
| 2025-12-31 | Betts Wendy J Director | Grant or award · Stock Options (Right to Buy) | +2,306 | $2.71 | $6K | 6,308 |
| 2025-12-31 | Burton Paul Frederick Director | Grant or award · Stock Options (Right to Buy) | +2,306 | $2.71 | $6K | 7,259 |
| 2025-12-31 | Intrater James Director | Grant or award · Stock Options (Right to Buy) | +2,306 | $2.71 | $6K | 7,259 |
| 2025-09-30 | Fung Peter K Director | Grant or award · Stock Options (Right to Buy) | +1,559 | $4.01 | $6K | 4,002 |
| 2025-09-30 | Betts Wendy J Director | Grant or award · Stock Options (Right to Buy) | +1,559 | $4.01 | $6K | 4,002 |
| 2025-09-30 | Burton Paul Frederick Director | Grant or award · Stock Options (Right to Buy) | +1,559 | $4.01 | $6K | 4,953 |
| 2025-09-30 | Intrater James Director | Grant or award · Stock Options (Right to Buy) | +1,559 | $4.01 | $6K | 4,953 |
Page 1 of 7 · 137 trades